# Emerging Technologies: Stakeholders

## Overview

Emerging technology governance involves diverse stakeholders with varying interests, expertise, and influence over policy outcomes.

## Research Community

### Academic Researchers

| Interest | Position |
|----------|----------|
| Research freedom | Resist restrictions |
| Funding | Support investment |
| Safety | Variable concern |
| Ethics | Growing attention |
| Publication | Open science |

**Influence**: Moderate (expertise, grants)

### Government Labs

| Actor | Focus |
|-------|-------|
| National labs | Multiple technologies |
| NIH | Biomedical |
| DOE | Energy, physics |
| DoD labs | Defense applications |
| NIST | Standards |

**Influence**: High (funding, expertise)

## Industry

### Large Technology Companies

| Company | Emerging Tech Focus |
|---------|---------------------|
| Google/Alphabet | AI, quantum |
| Microsoft | AI, quantum |
| IBM | Quantum, AI |
| Amazon | AI, space |
| Meta | XR, AI |
| Apple | AR, health tech |

**Interest**: Market access, light regulation, IP protection

### Startups and Emerging Players

| Sector | Examples |
|--------|----------|
| Biotech | Numerous |
| Quantum | IonQ, Rigetti |
| Neurotech | Neuralink, Synchron |
| Space | SpaceX, Blue Origin |
| Fusion | Commonwealth, TAE |

**Interest**: Investment, regulatory clarity, market access

### Industry Associations

| Association | Focus |
|-------------|-------|
| BIO | Biotechnology |
| TechNet | Large tech |
| SEMI | Semiconductors |
| Various startup groups | Emerging sectors |

**Interest**: Industry-favorable regulation

## Government

### Executive Branch

| Agency | Role |
|--------|------|
| OSTP | Coordination, policy |
| NSF | Research funding |
| DARPA | Defense R&D |
| NIH | Biomedical |
| DOE | Energy technologies |
| FDA | Medical products |
| EPA | Environmental |
| NIST | Standards |

**Interest**: Mission, competitiveness, safety

### Congress

| Committee | Jurisdiction |
|-----------|--------------|
| Senate Commerce | Technology |
| House Science | R&D, OSTP |
| Appropriations | Funding |
| Armed Services | Defense tech |
| Various | Specific technologies |

**Interest**: Constituent, national interests

### Intelligence Community

| Agency | Interest |
|--------|----------|
| NSA | Cryptography, quantum |
| CIA | Foreign tech assessment |
| ODNI | Coordination |
| DIA | Defense technology |

**Interest**: National security, intelligence advantage

## Civil Society

### Safety and Ethics Organizations

| Organization | Focus |
|--------------|-------|
| Future of Life Institute | Existential risk |
| Partnership on AI | AI ethics |
| Center for AI Safety | AI safety research |
| Various bioethics groups | Biotechnology |

**Interest**: Safety, ethics, oversight

### Public Interest Groups

| Organization | Focus |
|--------------|-------|
| EFF | Digital rights |
| ACLU | Civil liberties |
| Public Citizen | Regulation |
| Various consumer groups | Consumer protection |

**Interest**: Rights, accountability, access

### Professional Associations

| Association | Focus |
|-------------|-------|
| IEEE | Engineering ethics |
| ACM | Computing |
| AAAS | Science policy |
| NAS | Science advice |

**Interest**: Professional standards, responsible research

## International

### Foreign Governments

| Actor | Interest |
|-------|----------|
| China | Technological leadership |
| EU | Regulation, competitiveness |
| UK | Innovation, standards |
| Japan | Technology development |
| Others | Access, development |

### International Organizations

| Organization | Role |
|--------------|------|
| UN agencies | Governance frameworks |
| OECD | Policy coordination |
| ISO | Standards |
| IAEA | Nuclear |
| WHO | Health |

**Interest**: Global coordination, standards

## General Public

### Affected Populations

| Group | Concern |
|-------|---------|
| Workers | Job displacement |
| Patients | Healthcare access |
| Consumers | Safety, privacy |
| Future generations | Long-term impacts |

**Influence**: Low (diffuse, unorganized)

### Public Opinion

| Attitude | Prevalence |
|----------|------------|
| Technology enthusiasm | Common |
| Risk concern | Growing |
| Trust in regulation | Variable |
| Knowledge | Limited |

## Stakeholder Dynamics

### Power Distribution

| Actor | Power |
|-------|-------|
| Industry | High (resources, expertise) |
| Government | High (authority, funding) |
| Research | Moderate (expertise) |
| Civil society | Low-moderate (advocacy) |
| Public | Low (diffuse) |

### Coalition Patterns

| Coalition | Members |
|-----------|---------|
| Pro-innovation | Industry, some researchers |
| Safety/ethics | Civil society, some researchers |
| National security | Defense, intelligence |
| Access/equity | Civil society, some researchers |

---

## Document Navigation

- Previous: [Root Causes](04-root-causes.md)
- Next: [Opposition](06-opposition.md)
